The Trump administration gave Republicans a legal rationale and secret target list on its military campaign against drug ...

The U.S. military carried out a 15th strike on an alleged "narco-trafficking vessel," said Defense Secretary Pete Hegseth, ...

Lawmakers from both parties criticized the Trump administration after Democrats were not invited to a briefing Wednesday on U ...

The top drug regulator at the Food and Drug Administration (FDA) resigned Sunday, according to officials, after being accused ...

Parents and clinicians are urged to review usage of certain health products for young children after federal authorities ...

A federal spokesperson said Dr. George Tidmarsh left the agency after federal lawyers began looking into “serious concerns ...

Food and Drug Administration's Center for Drug Evaluation and Research, George Tidmarsh, resigned on Sunday amid serious ...

Texas Attorney General Ken Paxton alleged Johnson & Johnson deceptively marketed the drug as safe for pregnant Texans.

FDA announces major reforms to streamline biosimilar approvals, potentially saving Americans billions on prescription drug costs by removing extra clinical trial requirements.

In any review of mifepristone, the FDA will now have to grapple with Judge Otake’s conclusion that the 2023 REMS decision for ...